http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101937660-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 |
| filingDate | 2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101937660-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating inflammasome mediated inflammatory disease |
| abstract | The present invention relates to a pharmaceutical composition for the prophylaxis or treatment of inflammus-mediated inflammatory diseases, which inhibits the formation of intracellular ASC polymer when 5-methylphenazin-1-one is used The present invention can promote the inhibition of the activity of inflammazol by the above-mentioned process, thereby exerting an effect for improving, preventing or treating the above-mentioned diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022195451-A1 |
| priorityDate | 2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.